Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Open-label Safety Study With SkyePharma FlutiForm HFA pMDI (100/10 µg and 250/10 µg) in Adult and Adolescent Patients With Asthma

NCT00394121 is registered in ClinicalTrials.gov with SkyePharma AG as lead sponsor.

NCT NCT00394121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00394121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Open-label Safety Study With SkyePharma FlutiForm HFA pMDI (100/10 µg and 250/10 µg) in Adult and Adolescent Patients With Asthma
Lead sponsor
SkyePharma AG
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
July 31, 2007
Enrollment
400 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

asthma